title: Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy.
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Sun Ae
authors.initials: SA
authors.lastname: Han
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Young Min
authors.initials: YM
authors.lastname: Yoon
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Wan Soo
authors.initials: WS
authors.lastname: Lee
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Yun Sung
authors.initials: YS
authors.lastname: Kim
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Byung Chul
authors.initials: BC
authors.lastname: Shin
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Jong Hoon
authors.initials: JH
authors.lastname: Chung
authors.affiliation: Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.
authors.forename: Hyun Lee
authors.initials: HL
authors.lastname: Kim
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000328:Adult; D000686:Amyloidosis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012074:Remission Induction; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D003520:Cyclophosphamide; D000068879:Adalimumab
keywords: Amyloidosis; Cyclophosphamide; Juvenile idiopathic arthritis